With a new generation of orthopedic surgeons being trained in robotic procedures, the technology is clearly here to stay. But how heavily should health systems currently invest?
On the heels of the 2019 American Academy of Orthopedic Surgeons Annual Meeting, Lumere Chief Medical Officer John Cherf, MD, and orthopedics device expert Simon Kerr evaluate the evidence related to patient outcomes with robotic systems. They also explore the latest on stemless shoulders and small joint implants, along with the impact of shifting care sites.
This Content is provided “AS IS”, with all faults and without any warranty of any kind; any and all warranties are expressly disclaimed. No information in this Content is, or should be construed as medical advice, a guarantee of any product safety or any endorsement of any product or service; use of this Content is at your own risk. Lumere shall not be liable, in any way, for any use of this Article or decisions made and/or actions taken based upon the contents herein. Discussion of experimental uses of drugs or medical product as described in this Content is for informational purposes only, and is not to be interpreted as an endorsement or encouragement of off-label use of any product.